digital health tools glp-1 weight management Not Losing on a GLP‑1? Here's What Could Be Happening GLP-1 Weight Loss Specialist in

This is because menopause brings hormonal changes like lower estrogen levels, which lead to a range of effects that include weight gain for many women

They rely on systems

the 2026 Part D $2,100 out-of-pocket cap limits annual Medicare beneficiary exposure

After years of use in practice, we use it in time-boxed, medically supervised courses (up to 12 months) with clear goals and monitoring

The NCE period for tirzepatide runs through May 13, 2027, which means generic companies may not file an ANDA seeking approval for a generic version of Mounjaro or Zepbound until May 13, 2026, with patent infringement lawsuits expected to occur in the following months